A new study suggests that high doses of vitamin D supplements could help reduce disease activity among multiple sclerosis ...

MUSETTE trial was designed to determine whether a higher dose of the currently approved OCREVUS IV 600 mg would provide ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase III MUSETTE trial ...

Discover how MS patients overcome challenges, raise awareness, and lead fulfilling careers in healthcare. Across the UAE, ...

A local naval officer is fearlessly facing his multiple sclerosis diagnosis, using his creativity and entrepreneurial skills ...

Fooling others — and himself — into believing his MS symptoms weren't a big deal wasn't a good approach, writes columnist Be.

Tom Nolan reviews this week’s research There are so many studies published about vitamin D—about a dozen each day—it’s hard to keep up. One that stands out is a double-blind randomised controlled ...

The patient support program Cycle Vita will be available for people with MS taking Bafiertam (monomethyl fumarate) starting ...

Charlotte Hargreaves-Wright was told by her doctor that she had anxiety before being diagnosed with MS - then she was refused ...

Roche Holdings AG (OTC:RHHBY) on Wednesday announced data from MUSETTE Phase 3 trial of a high dose of Ocrevus (ocrelizumab) ...

A new study has found that eating fish could help to slow the progression of multiple sclerosis (MS). We look at the research ...

The proposal, HB477, backed by Rep. David Faulkner, would create an unregulated health plan exclusively for members of the ...